Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT06180668 |
Other study ID # |
GlobalTraumaLaprotomy |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
April 2024 |
Est. completion date |
February 2025 |
Study information
Verified date |
December 2023 |
Source |
University of Cambridge |
Contact |
Michael F Bath, MBChB |
Phone |
+44 (0)1223748577 |
Email |
mb2583[@]cam.ac.uk |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
The goal of this observational study is to assessing the global variation in patient
characteristics, management, and outcomes in those undergoing trauma laparotomy.
The main questions it aims to answer are:
- What are the post-operative mortality rates for patients undergoing a trauma laparotomy
globally
- What are the epidemiological characteristics (demographics, injury characteristics,
baseline clinical characteristics, and surgical case mix) for patients undergoing a
trauma laparotomy
- What are the pre-operative, peri-operative, and post-operative processes of care for
patients undergoing a trauma laparotomy
This is a purely observational study on patients undergoing trauma laparotomy, with no direct
change to clinical care.
Description:
We will conduct a prospective multi-centre observational cohort study of patients undergoing
a trauma laparotomy. We will recruit centres through pre-existing research networks,
utilising a snowballing technique to expand registration of centres. We will enrol eligible
patients undergoing emergency trauma laparotomy over a consecutive 30 day period at
individual centres during the study dates, with patients followed until discharge, death, or
30 days post-operatively, whichever comes first. All data will be submitted to a central
study team by 30 days after the end of their respective data study period.
Any hospital worldwide that performs emergency trauma surgery will be eligible to
participate, including both trauma centres and trauma units; a minimum of 1 case must be
submitted by the centre during the 30 day study period to be eligible. Each centre's team
will be comprised of a local study lead, with maximum 3 members of the local study team for
each data collection period. Independent data validators will be also required for select
centres.
We will include patients of all ages who present to hospital with a blunt or penetrating
injury and undergo a trauma laparotomy within 5 days of presentation to the treating centre
(day 0 being time of presentation). A patient will be included for final analysis if >70% of
the data points required have been recorded.
Exclusion criteria are:
- Patients undergoing a laparotomy ≥ 5 days (i.e. 120 hours) since presentation to the
treating centre
- Any relook laparotomy, including transfers from another centre for further and / or
definitive surgery
- Any laparoscopic (including laparoscopic converted to open), robotic, or image-guided
procedures
- Patients who have been recently discharged from any hospital (including for non-trauma
related admissions) and have represented within 30 days of discharge
We aim to collect system, patient, process, and outcome data. A data set will be collected on
all patients undergoing a trauma laparotomy within the inclusion period. The included data
fields were based on work by similar studies and refined through iterative consultation with
a global interdisciplinary consortium of clinicians involved in trauma care.
Data will be collected through access to patient records only at each centre, performed by
members of the local study team. The patient will not be contacted directly in any capacity
during their inpatient stay or after the study and no direct involvement in patient care will
occur. Data will be collected directly onto a well-established secure web-based system,
REDCap cloud (or recorded temporarily onto a hard copy Data Collection Form and uploaded to
REDCap at a later date)
The data collected will include a pragmatic set of variables that allow the proposed research
to be conducted, but minimise both risk of identification and exclude extraneous possibly
sensitive medical information. Local requisite ethics and approvals will be applied for and
be in place before any data collection occurs.